Spatial metabolic modulation in vascular dementia by Erigeron breviscapus injection using ambient mass spectrometry imaging
Phytomedicine,
Год журнала:
2025,
Номер
unknown, С. 156412 - 156412
Опубликована: Янв. 1, 2025
Язык: Английский
Unraveling the role of brain renin angiotensin system in vascular dementia: mechanisms and therapeutic perspectives
Kuldeep Kumar,
Sonal Aggarwal,
Ayush Kandpal
и другие.
Experimental Brain Research,
Год журнала:
2025,
Номер
243(5)
Опубликована: Апрель 26, 2025
Язык: Английский
Interaction Between DHCR24 and hsa_circ_0015335 Facilitates Cognitive Impairment in Cerebral Small Vessel Disease Patients
CNS Neuroscience & Therapeutics,
Год журнала:
2024,
Номер
30(11)
Опубликована: Ноя. 1, 2024
ABSTRACT
Aims
The
study
attempted
to
determine
the
underlying
role
and
regulation
mechanism
of
3β‐hydroxysterol‐Δ24
reductase
(DHCR24)
in
pathophysiology
cerebral
small
vessel
disease‐associated
cognitive
impairment
(CSVD‐CI).
An
RNA
high‐throughput
sequencing
independent
verification
were
conducted
identify
potential
circRNAs
becoming
upstream
regulator.
Methods
was
performed
whole‐blood
samples
cohort
1
(10
CSVD‐CI
8
CSVD
with
cognitively
normal
[CSVD‐CN]
patients).
DHCR24
candidate
verified
an
2
(45
participants
37
CSVD‐CN
ones).
also
analyzed
comprehensive
assessments,
plasma
molecular
index,
brain
structure
imaging.
Results
expression
has_circ_0015335
patients
significantly
reduced
compared
verification.
Furthermore,
levels
related
global
patients.
Meanwhile,
could
regulate
correlation
between
alterations
cortex
surface
area,
thickness,
volume
Additionally,
hsa_circ_0015335
interacted
for
24(S)‐hydroxycholesterol
among
Conclusion
Interaction
impaired
by
affecting
cholesterol
metabolism
structural
changes.
Язык: Английский
Liver enzyme and risk of vascular dementia: A univariable and multivariable Mendelian randomization of European descent
Neuroprotection/Neuroprotection (Chichester, England. Print),
Год журнала:
2024,
Номер
2(4), С. 310 - 317
Опубликована: Дек. 1, 2024
Abstract
Background
Observational
studies
have
indicated
a
link
between
liver
enzymes
and
dementia,
but
the
causal
relationship
remains
uncertain.
We
conducted
two‐sample
Mendelian
randomization
(MR)
study
to
investigate
potential
links
function
markers
(alanine
aminotransferase
[ALT],
aspartate
[AST],
alkaline
phosphatase
[ALP],
γ‐glutamyltransferase
[GGT])
various
forms
of
dementia
(all‐cause
Alzheimer's
disease
[AD],
vascular
[VaD],
frontotemporal
[FTD]).
Methods
Genome‐wide
association
(GWAS)
data
enzyme
levels
with
517
single
nucleotide
polymorphisms
from
315,572
individuals
European
descent
were
considered
as
exposures.
Additional
GWAS
on
FinnGen
consortium
UK
Biobank
used
outcomes.
The
was
evaluated
using
univariable
MR
(UVMR)
multivariable
(MVMR)
methods.
UVMR
approaches
such
inverse
variance
weighting
(IVW),
MR‐Egger,
weighted
median,
simple
mode,
mode
used,
IVW
primary.
MVMR
techniques,
extended
versions
IVW,
Q‐minimization
methods,
assess
effects.
robustness
analysis
findings
verified
through
heterogeneity,
horizontal
pleiotropy,
leave‐one‐out
analyses.
Results
demonstrated
that
genetically
determined
one
standard
deviation
rise
in
blood
GGT
associated
an
increased
risk
VaD
(IVW:
odds
ratio
=
1.007,
95%
confidence
interval
1.002–1.011,
p
0.010).
These
remained
consistent
after
adjusting
for
confounding
variables
analysis.
Sensitivity
analyses
further
supported
relationship.
However,
no
significant
observed
ALT,
AST,
ALP,
all‐cause
VaD,
AD,
or
FTD.
Conclusions
Our
suggests
clinical
implications,
demonstrating
high
concentrations
are
factors
populations.
Further
research
is
needed
uncover
underlying
biological
mechanisms
validate
relevance
early
prevention
intervention
strategies.
Язык: Английский